Cartesian Therapeutics, Inc. — Director's Dealing 2016

Jun 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21

Reporting Person: Johnston Lloyd P. (COO and SVP, R&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-21	Employee Stock Option (right to buy)	$14.00	A	27617	Acquired	2026-06-20	Common Stock (27617)	Direct

Footnotes

F1: The option will vest as to 25% of the shares on June 21, 2017. The remainder of the shares will vest in 36 equal monthly installments thereafter.